VOYA Investment Management
ORKA

VOYA Investment Management’s Oruka Therapeutics ORKA Stock Holding History

VOYA Investment Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.2M Buy
401,149
+334,549
+502% +$22.3M 0.03% 371
2026
Q1 		$3.27M Buy
66,600
+24,097
+57% +$837K ﹤0.01% 1008
2025
Q4 		$1.29M Buy
+42,503
New +$1.18M ﹤0.01% 1394

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

VOYA Investment Management's ORKA Position: Q2 2026 in Review

VOYA Investment Management increased its Oruka Therapeutics (ORKA) stake by 502% in Q2 2026, buying an estimated $22.3M and bringing the position to 401,149 shares worth $38.2M. The position accounts for 0.03% of the portfolio, ranked #371.

VOYA Investment Management first reported a position in ORKA in Q4 2025 and has held it in 3 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • VOYA Investment Management held 401,149 shares of Oruka Therapeutics worth $38.2M as of Q2 2026.
  • VOYA Investment Management bought 334,549 Oruka Therapeutics shares in Q2 2026, an estimated $22.3M.
  • Oruka Therapeutics made up 0.03% of VOYA Investment Management's portfolio in Q2 2026, its #371 holding.
  • VOYA Investment Management first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.